Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

BBO-8520 monotherapy in patients with KRASG12C non-small cell lung cancer (NSCLC) showed a 65% objective response rate (ORR) and a 66% 6-month ...

Organised by the Beijing-Hong Kong Academic Exchange Centre, the results of the annual selection for the ‘Top 10 Innovation & ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

NDA supported by results from a Phase II registration trial in China —— Second most common form of liver cancer after hepatocellular carcinoma, ...

A high-fat diet does more than overload the liver with fat. New research from MIT shows that prolonged exposure to fatty ...

Liver cells exposed to a high fat diet revert to an immature state that is more susceptible to cancer-causing mutations.

Abstract: Companies in the healthcare industry would be foolish to disregard medical analytics and decision-making tools that employ multi-modal intelligence. Liver cancer, among the most prevalent ...

Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...

COVID-19 mRNA vaccines create enough of an immunity boost to extend survival in certain types of lung and skin cancers, an analysis of more than 1,000 patient files showed. The scientific journal ...

A new study has found that while comorbid conditions are often factored into cancer prognoses, it is older age, rather than overall comorbidity burden, that is most strongly linked to poorer survival ...